India News | COVID-19: Tamil Nadu Gives Nod to ICMR for Studying BCG Vaccine's Efficacy on Senior Citizens
Get latest articles and stories on India at LatestLY. In view of the coronavirus outbreak, Chief Minister Edappadi K Palaniswami has given approval to Indian Council of Medical Research (ICMR) for studying the efficacy of the Bacillus Calmette-Guerin (BCG) vaccine on senior citizens at its National Institute for Research in Tuberculosis (NIRT) at Chennai.
Chennai (Tamil Nadu) [India], July 15 (ANI): In view of the coronavirus outbreak, Chief Minister Edappadi K Palaniswami has given approval to Indian Council of Medical Research (ICMR) for studying the efficacy of the Bacillus Calmette-Guerin (BCG) vaccine on senior citizens at its National Institute for Research in Tuberculosis (NIRT) at Chennai.
This comes after ICMR sought the Tamil Nadu government's permission for the study.
The ICMR's tuberculosis institute is set to begin the trial very soon for coronavirus-infected senior citizens aged between 60 to 95.
Tamil Nadu Health Minister Dr C Vijayabaskar said the BCG vaccine is aimed at reducing the COVID-19 mortality rate among senior citizens.
Also Read | Hyderabad: Water Enters Osmania General Hospital After Rain For Second Time in a Week, Watch Video.
"BCG vaccine shall be administered on trial basis for adults aged 60-95, ordered by Hon'ble CMO Tamil Nadu. This is aimed at reducing the COVID mortality rate in senior people. National Institute for Research in Tuberculosis will start the pilot programme soon," Vijayabaskar said in a tweet. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)